Picture of Cyxone AB logo

CYXO — Cyxone AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Cyxone Submits Application To Start First-In-Human Trial With T20k In MS

May 23 (Reuters) - Cyxone AB  CYXO.ST :
    * CYXONE SUBMITS APPLICATION TO START FIRST-IN-HUMAN TRIAL
WITH
T20K IN MS
    * APPLICATION TO START FIRST-IN-HUMAN CLINICAL TRIAL FOR
T20K IN
MS WILL ON MONDAY MAY 27 BE SUBMITTED TO AUTHORITIES IN
NETHERLANDS

Source text for Eikon:  ID:nWkr1NDzKl 
Further company coverage:  CYXO.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Cyxone AB

See all news